Skip to content

Effect of the test food on walking function.

Effect of the test food on walking function. - Effect of the test food on walking function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048093
Enrollment
60
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

two weeks intake of the test food1 two weeks intake of the test food2 two weeks intake of the test food3

Sponsors

ITOEN, LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese men and women aged 20 years and older and aged 60 to 75 years at the time of informed consent 2) Subject who is able to take 9 capsules daily for 2 weeks. 3) Non smoker 4) Subject who has received sufficient explanation of the purpose and content of the research, is capable of giving informed consent, voluntarily volunteers to participate in the research, and consents to participate in the research in writing.

Exclusion criteria

Exclusion criteria: 1) Subject who is currently receiving any medications or outpatient treatment. 2)Subject who is currently doing exercise or diet under the supervision of a doctor 3)Subject who is may develop allergy due to the test food 4)Subject who is drug dependent, present or dependent on alcohol 5) Subject who is history of psychiatry during hospitalization due to mental disorder (depression etc.) or sleep disorder (insomnia, sleep apnea syndrome etc.) 6)Night shift or shift workers 7) Excessively irregular lifestyle such as eating or sleeping 8) Subject who is extreme skipped eating 9)Subject who is current disease or history of diabetes, liver disease (hepatitis), kidney disease, serious disease such as heart disease, thyroid disease, adrenal disease, other metabolic diseases 10)Subject who is use health foods, supplements, and medicines that may affect cognitive function 11) Subject who is participated in other human clinical studies within the past 3 months or are expected to participate in other human clinical studies during the study period. 12)Subject who is carried out blood collection, component blood donation more than 400 mL within 200 mL or 3 months within one month going back from the date of consent acquisition 13) Subject who is pregnant, breast-feeding, or willing to become pregnant during the study period 14)Subject who is difficult to comply with the records of various surveys 15)Subject who is judged to be unsuitable as subject from clinical laboratory test value and measurement value at the time of SCR 16)Other than the above, the principal investigator judged that the subject was ineligible for the study.

Design outcomes

Primary

MeasureTime frame
gait, electroencephalography

Countries

Japan

Contacts

Public ContactYoshitake Baba

ITOEN, LTD. Central Research Institute

yoshi-baba@itoen.co.jp0548-54-1247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026